. Development of CDD-0102 as a selective M1 agonist for the treatment of Alzheimer’s disease. Drug Dev Res. 2002 Dec;57(4):200-13.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.